AI-generated summary
The authors report a randomized, double-blind, placebo-controlled trial of 44 people with temporomandibular dysfunction comparing three photobiomodulation doses with an 830-nm laser against a control group. They found that pain decreased in all groups, and that only the 8 J/cm2 dose was associated with improved mouth opening and mandible protrusion. The abstract does not state a long-term follow-up period.
- Participants
- 44
- Who or what was studied
- Adults with temporomandibular dysfunction (TMD); the abstract does not describe further demographic details.
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract reports only four groups of 11 subjects each, so the sample per group is small, and it gives no follow-up duration.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 8 J/cm2, 60 J/cm2, 105 J/cm2
- Power density (irradiance)
- 30 mW/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Placebo-controlled, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.